Strategic Design of an Effective β-Lactamase Inhibitor
Open Access
- 1 January 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (2), 945-953
- https://doi.org/10.1074/jbc.m806833200
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Extended-spectrum β-lactamases in ambulatory care: a clinical perspectiveClinical Microbiology & Infection, 2008
- Molecular mechanism of ferricsiderophore passage through the outer membrane receptor proteins of Escherichia coliBioMetals, 2006
- Role of Asp104 in the SHV β-LactamaseAntimicrobial Agents and Chemotherapy, 2006
- Rational Design of a β-Lactamase Inhibitor Achieved via Stabilization of the trans-Enamine Intermediate: 1.28 Å Crystal Structure of wt SHV-1 Complex with a Penam SulfoneJournal of the American Chemical Society, 2006
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004
- Evaluation of penicillin-based inhibitors of the class A and B β-lactamases from Bacillus anthracisBiochemical and Biophysical Research Communications, 2004
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Inactivation of CMY-2 β-lactamase by tazobactam: initial mass spectroscopic characterizationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2001
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997